About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

SEIKAGAKU CORPORATION(4548) Summary

4548
TSE Prime
SEIKAGAKU CORPORATION
667
JPY
-5
(-0.74%)
Apr 16, 3:30 pm JST
4.68
USD
Apr 16, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
22.0
PBR
0.49
Yield
4.50%
Margin Trading Ratio
16.63
Stock Price
Apr 16, 2025
Opening Apr 16, 9:00 am
675 JPY 4.71 USD
Previous Close Apr 15
672 JPY 4.69 USD
High Apr 16, 9:02 am
677 JPY 4.73 USD
Low Apr 16, 2:20 pm
664 JPY 4.66 USD
Volume
74,100
Trading Value
0.05B JPY 0.35M USD
VWAP
669.28 JPY 4.7 USD
Minimum Trading Value
66,700 JPY 468 USD
Market Cap
0.04T JPY 0.27B USD
Number of Trades
204
Liquidity & Number of Trades
As of Apr 16, 2025
Liquidity
Mid
1-Year Average
247
1-Year High May 14, 2024
1,031
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 11, 2025 13,400 427,800 31.93
Apr 4, 2025 12,100 469,900 38.83
Mar 28, 2025 12,500 334,500 26.76
Mar 21, 2025 11,800 286,700 24.30
Mar 14, 2025 11,500 291,000 25.30
Company Profile
SEIKAGAKU CORPORATION specializes in the development of products related to joint diseases. Its hyaluronic acid preparations are distributed through partnerships with Kaken Pharmaceutical and Santen Pharmaceutical.
Sector
Pharmaceuticals
SEIKAGAKU CORPORATION engages in the research, development, manufacturing, procurement, and sales of pharmaceuticals and LAL (Limulus Amebocyte Lysate) products, including endotoxin detection reagents. In its pharmaceutical business, the company focuses on joint function improving agents as its main product line, while also offering ophthalmic surgical aids and treatments for lumbar disc herniation. Additionally, the company manufactures pharmaceutical ingredients and provides contract manufacturing services for pharmaceuticals. In the LAL business, SEIKAGAKU CORPORATION offers endotoxin detection reagents and glucan measurement in vitro diagnostic products. The company has several subsidiaries both domestically and internationally, conducting pharmaceutical and medical device development in North America, as well as manufacturing and sales operations overseas.